N (%) | Univariate analysis | Multivariable analysis | |||
---|---|---|---|---|---|
P-value | hazard ratio | 95% CIe | P-value | ||
Age: > 70 (vs. ≤ 70) | 19 (44) | 0.454 | |||
Sex: female (vs. male) | 13 (30) | 0.447 | |||
ECOG PSa: 1–2 (vs. 0) | 32 (74) | 0.189 | 1.450 | 0.523–4.026 | 0.475 |
Disease status: recurrence (vs. metastatic) | 9 (21) | 0.222 | |||
Treatment line: 4th or later (vs. 3rd) | 9 (21) | 0.112 | 0.503 | 0.205–1.239 | 0.135 |
CEAb(ng/mL): > 10.0 (vs. ≤ 10.0) | 23 (53) | 0.012 | 1.958 | 0.845–4.537 | 0.117 |
CA 19–9c (U/mL): > 2000 (vs. ≤ 2000) | 24 (56) | 0.122 | 0.434 | 0.651–2.720 | 0.434 |
Albumin (g/dL): ≤ 3.5 (vs. > 3.5) | 24 (56) | 0.663 | |||
CRPd (mg/dL): > 1.0 (vs. ≤ 1.0) | 16 (37) | 0.021 | 2.037 | 1.010–4.107 | 0.047 |